7月 2026
- 首頁
- MPI Research, Inc.
7月 2026MPI Research, Inc.的市場佔有率分析
charles river provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.
MPI Research, Inc.(包含公司地區)
查看更多網站流量與參與度資訊- mpiresearch.com
MPI Research, Inc.截至 7月 2026 的總收入為 200M - 500M
MPI Research, Inc. 熱門網域產生的總收入
MPI Research, Inc. 熱門網域 3 年內的總收入
MPI Research, Inc. 熱門網域的總收入
MPI Research, Inc.的熱門網域總造訪量
了解MPI Research, Inc.市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
無可顯示數據
無可顯示數據
MPI Research, Inc.的熱門網域平均造訪時長
分析MPI Research, Inc.參與度指標。
過去 3 個月平均造訪時長
無可顯示數據
無可顯示數據
MPI Research, Inc.的熱門網域平均頁面瀏覽量
了解MPI Research, Inc.如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
無可顯示數據
無可顯示數據
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自MPI Research, Inc.
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Charles River Laboratories International, Inc. acquired MPI Research, Inc. for $800M on Feb 13th '18.Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has entered into a definitive agreement to acquire MPI Research for approximately $800 million in cash, subject to customary closing adjustments.
2月 13, 2018閱讀更多
新聞MPI Research, Inc. is developing large mammalian preclinical models for various ophthalmic diseases on Apr 30th '17.EyeCRO and MPI Research, two global leaders in preclinical ophthalmology contract research, today announced a collaboration to develop and commercialize large mammalian preclinical models for various ophthalmic diseases, including Age-Related Macular Degeneration and Diabetic Retinopathy.
5月 1, 2017閱讀更多
新聞MPI Research, Inc. hired Susan Buckham as vice president of operations on Nov 1st '16.Mattawan-based MPI Research said last month it has named Susan Buckham as its VP of operations.
12月 23, 2016閱讀更多
查看所有MPI Research, Inc.信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
